Hassles with taking out the garbage: Aggravating aggresomes

Traffic

Volumn 3, Issue 6, 2002, Pages 388-396

  Garcia Mata, Rafael ^a   Gao, Ya Sheng ^a   Sztul, Elizabeth ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Aggregation; Aggresome; Autophagy; Chaperones; Degradation; Intermediate filament; Misfolding; Neurodegeneration; Proteasome

Indexed keywords

CHAPERONE; DYNEIN ADENOSINE TRIPHOSPHATASE; PROTEASOME;

AMYLOIDOSIS; AUTOPHAGY; CONTROLLED STUDY; CYTOPLASM; ENZYME DEGRADATION; LYSOSOME; MICROTUBULE; MICROTUBULE ORGANIZING CENTER; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN TRANSPORT; REVIEW; CYTOSKELETON; GENERAL ASPECTS OF DISEASE; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN DENATURATION;

CYTOSKELETON; DISEASE; HUMANS; LYSOSOMES; PROTEIN DENATURATION; PROTEIN FOLDING;

EID: 0036303981     PISSN: 13989219     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0854.2002.30602.x     Document Type: Review

References (55)

1. Protein folding local structures, domains, subunits, and assemblies
2. Mutations and off-pathway aggregation of proteins
3. Estimation of macromolecule concentrations and excluded volume effects for the cytoplasm of Escherichia coli
4. Principles of protein folding in the cellular environment
5. Implications of macromolecular crowding for protein assembly
6. Pre-Golgi degradation of newly synthesized T-cell antigen receptor chains: Intrinsic sensitivity and the role of subunit assembly
7. A role for destabilizing amino acid replacements in light-chain amyloidosis
8. Posttranslational quality control folding, refolding, and degrading proteins
9. Protein folding in the cytosol: Chaperonin-dependent and -independent mechanisms
10. Molecular chaperones in cellular protein folding
11. Characterization of the active intermediate of a GroEL-GroES-mediated protein folding reaction
12. In vivo newly translated polypeptides are sequestered in a protected folding environment
13. The ubiquitin system
14. Intracellular targeting of the proteasome
15. ER quality control: Towards an understanding at the molecular level
16. Ubiquitin and the control of protein fate in the secretory and endocytic pathways
17. Characterization and dynamics of aggresome formation by a cytosolic GFP-chimera
18. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis
19. Aggresomes: A cellular response to misfolded proteins
20. ER-to-Golgi transport visualized in living cells
21. Motors and membrane traffic
22. Interaction of huntingtin-associated protein with dynactin P15OGlued
23. Huntington aggregates may not predict neuronal death in Huntington's disease
24. Nuclear and neuropil aggregates in Huntington's disease: Relationship to neuropathology
25. Structurally abnormal immunoglobulins in human immunoproliferative disorders
26. Mechanisms of disease: Monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease
27. Hsp7O and antifibrillogenic peptides promote degradation and inhibit intracellular aggregation of amyloidogenic light chains
28. Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form Mallory bodies
29. A mutation of the Wilson disease protein, ATP7B, is degraded in the proteasomes and forms protein aggregates
30. Dynamic association of proteasomal machinery with the centrosome
31. Phosphorylation-induced change of the oligomerization state of alpha B-crystallin
32. Chaperone-like activity of synucleins
33. Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation
34. Hsp7O and hsp4O chaperones can inhibit self-assembly of polyglutamine proteins into annyloid-like fibrils
35. Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors
36. Activity and regulation of the centrosome-associated proteasome
37. Degradation of CFTR by the ubiquitin-proteasome pathway
38. Autophagy
39. Ubiquitin-mediated proteolysis centers in HeLa cells: Indication from studies of an inhibitor of the chymotrypsin-like activity of the proteasome
40. Proteasome inhibitors activate stress kinases and induce Hsp72. Diverse effects on apoptosis
41. Protein kinase cascades activated by stress and inflammatory cytokines
42. Episodic ataxia type-1 mutations in the Kv1.1 potassium channel display distinct folding and intracellular trafficking properties
43. Intermediate filament-ubiquitin diseases: Implications for cell sanitization
44. Ubiquitin and the molecular pathology of neurodegenerative diseases
45. Aggregation of mutant Cu/Zn superoxide dismutase proteins in a culture model of ALS
46. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1
47. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders
48. Neurological abnormalities in a knock-in mouse model of Huntington's disease
49. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
50. The fatal attraction of polyglutamine-containing proteins
51. Glutamine repeats and neurodegeneration
52. Specificity in intracellular protein aggregation and inclusion body formation
53. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity
54. Amyloid formation by mutant huntingtin: Threshold, progressivity and recruitment of normal polyglutamine proteins
55. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation